Environmental factors are important in the aetiology of glucose intolerance, type I1 diabetes and IHD. The lack of vitamin D, which is necessary for adequate insulin secretion, relates demographically to increased risk of myocardial infarction. These disorders are connected, degenerative vascular disease increasing with glucose intolerance and diabetes and, with its risk factors, comprising syndrome 'X'. Evidence is presented suggesting that vitamin D deficiency may be an avoidable risk factor for syndrome 'X', adding another preventative measure to current recommendations which are aimed at reducing the worldwide epidemic of these disorders. Experimentally, vitamin D deficiency progressively reduces insulin secretion; glucose intolerance follows and becomes irreversible. Relationships between vitamin D status, glucose tolerance and 30 min insulin secretion during oral glucose tolerance tests are reported in British Asians; insulin secretion, but not glycaemia, improving with short-term supplementation. Studies showing reduction in blood pressure and in risk of heart attack and diabetes with exercise (usually outdoor), rarely consider the role of vitamin D status. Glycaemia and insulin secretion in elderly European men, however, relate to vitamin D status, independent of season or physical activity. Prolonged supplementation can improve glycaemia. Hypertension improves with vitamin D treatment with or without initial deficiency. Vitamin D status and climate are reviewed as risk factors for myocardial infarction; the risk reducing with altitude despite increasing cold. Glycaemia and fibrinogenaemia improve and insulin secretion increases in summer. Variation in vitamin D requirements could arise from genetic differences in vitamin D processing since bone density can vary with vitamin D-receptor genotype. Vitamin D receptors are present in islet cells and we report insulin secretion in healthy Asians differing profoundly with the Apa I genotype, being independent of vitamin D status. Those at risk of vitamin D deficiency include the elderly, those living indoors or having a covered-up style of dress, especially dark-skinned immigrants, and pregnant women, and these are groups recognized as being at increased risk of diabetes.
non-insulin-dependent diabetes (NIDDM) in this ethnic group, compared with that in Caucasians, remains an ever present challenge (McKeigue et a/. 1992) . In addition, we still see clinical osteomalacia locally, so that we have had to consider whether lack of vitamin D might be contributing to the increased prevalence of NIDDM in local Asian residents, in addition to the possible diabetogenicity of dietary factors, such as. betel-nut (Aveca catechu; pan), in this population (Boucher et a/. 1994) . The high prevalence of both diabetes and osteomalacia in British Asians noted in 1986 led to the comment that 'whether their vitamin D deficiency contributes to the pathogenesis of their diabetes is an area ripe for investigation' (Dandona et al. 1986 ).
Syndrome 'X'
Syndrome 'X', as described by Reaven (1995) , is the term used to describe a cluster of disorders linked to insulin resistance, with the potential risk of glucose intolerance and eventual diabetes, and is especially common in immigrant Asians. Reavens' syndrome covers both the changes in the blood which increase the risk of clotting and those, such as the hyperlipidaemias, accelerating degenerative changes in the vasculature; factors which together cause increases in the incidence of strokes and heart attacks. Since Asians resident in the UK have an increased death rate from heart attack and stroke compared with those of indigenous Caucasians (Balarajan, I996) , this group of disorders presents a major health problem.
The scale of the health problems associated with syndrome 'X' can be appreciated when one considers that this term describes a clustering of disorders leading to degenerative diseases of the vasculature which account for one-third of deaths in the Western world. Impaired glucose tolerance (IGT) and NIDDM are common and carry equal increases in risk of heart'disease. IGT and NIDDM are increasingly common, NIDDM affecting 3 % of Caucasians, 7 % of Americans over 40 years of age and at least 10 % of urban Asians in the Western world. The prevalence of NIDDM can be as high as 40-60 % in some populations which may carry a similar prevalence of IGT in addition, and the prevalence of both disorders increases in all groups with age. Atheromatous disease in diabetics increases standardized mortality rates 2-3-fold, 50 % of diabetics develop hypertension and 15-20 % of hypertensives have IGT, carrying the same risks as diabetes even though progression to diabetes is not invariable (Ferranini et al. 1987; Hjermann, 1992) .
Specific disorders found in syndrome 'X', with or without the overt development of glucose intolerance. include hypertriacylglycerolaemia, raised LDL-and reduced HDL-cholesterol, hypertension, central (intra-abdominal) obesity and reduced insulin secretion, increased insulin resistance being an early and fundamental feature (see Table 1 ). Fasting hyperinsulinaemia, reflecting insulin resistance, impairment of glucose tolerance and eventual diabetes are common features, whilst increases in circulating free fatty acids, fibrinogen, plasminogen-activator inhibitor and reductions in fibrinolysis are also found (Kannel er a/. 199 1; Dhawan et a/. 1994). The recent increase in prevalence of this group of disorders in the last 30 years has led to the idea that they must have resulted from some evolutionary advantage. The 'Thrifty Genotype' hypothesis proposes this to be an enhanced ability to survive famine by increasing body fat stores in times of plenty (Neel, 1962) . Alternatively the 'Thrifty Phenotype' hypothesis suggests that dietary deficiency in pregnancy acts as a trigger for the disorders comprising syndrome 'X', since the prevalence of adult diabetes, hypertension and hypertriacylglycerolaemia has been demonstrated to increase progressively with reduction in full-term birth weight in many different population groups, studied both in childhood and over the age of 50 years (Hales & Barker, 1992; Barker et al. 1993; Phillips et al. 1994) . Insulin resistance, an integral part of this syndrome, has recently been shown to be increased in otherwise healthy adults who had been small babies, despite the absence of any other detectable feature of syndrome 'X' (Phillips et al. 1994) . Reducing dietary protein intake from 200 to 80g/kg in isoenergetic diets during gestation can induce permanent alterations in metabolic processes in the liver in experimental animals (Petrie et al. 1997) , together with increases in cortisol secretion (Phillips et al. 1997) .
The mechanisms by which such fetal programming is induced are being worked out and include permanent alterations in liver enzyme activities (Desai et a/. 1997a) . However, it is not necessarily the case that protein will prove to be the only maternal nutrient of importance in this respect. Recent dramatic falls in the prevalence of NIDDM in less than 20 years, from the 40 % found in well-nourished Nauruans who were the offspring of a malnourished population, to the 20% found in their descendants in the current generation of Nauruans (Dowse et a/. 1991) , suggest that genetic factors are unlikely to outweigh nutritional or other environmental factors in the causation of type 2 diabetes mellitus in that population.
Whilst genetic differences between populations are thought to play a large part in determining susceptibility to NIDDM, environmental factors, or 'triggers', are also active in its induction (see Table 1 ; WHO Study Group, 1985; Khaw, 1994; Boucher, 1995) .
The hypothesis
1n view of the requirement of the p cell for vitamin D and of the high prevalence of vitamin D deficiency in many population groups, such as the elderly and immigrant Asians, the postulate that vitamin D deficiency is an avoidable risk factor for IGT and NIDDM, and thus also of diseases related to syndrome 'X', appears to be worthy of more general consideration. Syndrome 'X' may comprise unrelated phenomena (Cruickshank, 1995) , but an overview of factors that could link disparate but common disorders is recommended when attempting to identify environmental triggers in common degenerative disorders where genetic predisposition may be necessary, but is not a sufficient explanation (LaPorte, 1995) . The present review attempts such an approach in examining the postulate that vitamin D insufficiency could contribute to the development of syndrome 'X' in man.
Vitamin D metabolism
The ways in which vitamin D insufficiency, loss of activation, or inhibition of action can arise are clearly relevant to consideration of the available evidence. Sunlight induces cholecalciferol formation in man, and in the absence of adequate exposure to U.V. light, a minimal daily dietary intake of 1Opg is required. The basic pathways involved in the formation and activation of the effector hormone calcitriol (1,25-dihydroxyvitamin D; 1 ,25(OH)2D) are shown in Fig. 1 . An outline of what is known of its receptor and post-receptor mechanisms follows. Hormonal vitamin D acts as a promotor for gene transcription of factors active in bone and in cells of the immune system. It also promotes cell differentiation and inhibits cell proliferation in many tissues and cell lines (Holick, 1995; Darwish et al. 1997) . It is likely, therefore, that its action on the B cell is to promote transcription of genes relevant to insulin secretion and release.
Evidence from animal studies
Normal insulin secretion is dependent on 1,25(OH)2D in both intact animals and isolated islets (Frankel et al. 1980; Kadowski et al. 1984; Nyomba et al. 1984; Billaudel et al. 1989; Levy et al. 1994) . One mechanism of action is likely to be the Ca dependence of one of the / 3 cell proinsulincleavage endopeptidases (Rhodes & Alarcon, 1994) . Ca is also necessary for exocytosis of insulin from the B cell, and for fl cell glycolysis which plays a part in signalling circulating glucose concentration (Milner & Hales 1967; Rutter et al. 1997) . First-phase insulin release in response to glucose is impaired in early vitamin D deficiency, followed in sustained deficiency by a reduction in secondphase insulin secretion. (Kadowski, 1985; Cade & Norman, 1986) .
A decrease in 25-hydroxy-vitamin D (25(OH)D) I-chydroxylase (EC 1.14.13.13) activity in the kidneys, which is thought to be secondary to insulin deficiency, has been reported in experimental diabetes (Ikeda et al. 1987) Increases in insulin resistance associated with reduction in vitamin D status have also been described, especially in uraemia where loss of lahydroxylation due to loss of nephrons produces an acquired deficiency state. This has been shown to improve after treatment with 1,25(OH)2D (Gedik et al. 1986; Lind et al. 1989a; Kocian, 1992; Mak, 1992b; Beaulieu et al. 1993; Kumar et al. 1994; Orwoll et al. 1994) . Vitamin D status has been shown to relate inversely to the severity of hypertension in Caucasian populations, both with and without vitamin D deficiency, and to have a similar inverse relationship to hypertriacylglycerolaemia (Lind et al. 1989b; Scragg et al. 1992; Barger-Lux & Heaney, 1994) . Serum 25(OH)D has also been found to relate directly to circulating apolipoprotein A-1 ( P < 0.001 in both men and women) and also to HDL-cholesterol ( P < 0.05 in men and P < 0.005 in women) in 358 Belgians (Auwerx et al. 1992) . Increased risk of myocardial infarction itself may be a feature of low vitamin D status, and the evidence for this has been comprehensively discussed by Scragg et al. (1992, 1 9 9 5~) and Scragg (1996) . An increased prevalence of myocardial infarction has been found in northern compared with southern European communities (e.g. Scotland v. England or Finland v. Italy) i.e. in those populations where vitamin D deficiency is more common (Balarajan et al. 1987) . Both freedom from deficiency of vitamin D and an increased Ca intake have been suggested as protective against IHD (Knox, 1973; McCarron & Morris, 1987) . Hypertension, a well-recognized risk factor for myocardial infarction, has been found to be increased with reduction in available Ca and to improve with Ca intake and with vitamin D supplementation in several studies, even when subjects were not initially deficient (Lind et al. 1988; Kishimoto et al. 1993) . Hypertension is well recognized as a feature of primary hyperparathyroidism. Improvement in the hypertension of spontaneously hypertensive rats with supplementary Ca is described. This is inhibited by continued administration of parathyroid hormone. In addition, correction of abnormal insulin resistance and glucose intolerance are well known after surgical cure of primary hyperparathyroidism (Kishimoto et al. 1993) , with cure of NIDDM in one instance (Quin & Gumpert, 1997).
The secondary hyperparathyroidism of vitamin D deficiency, as reported in other Indo-Asian diabetic patients (Serhan ef al. 1997) , may contribute, therefore, to the production of both glucose intolerance and of hypertension and to their progressive deterioration once diabetes is established.
Seasonal effects in man
Blood pressure, serum triacylglycerol and fibrinogen concentrations are higher in January and February than in July and August in UK Caucasians (Woodhouse et al. 1993 (Woodhouse et al. , 1994 Scarabin et al. 1994) . These findings have been attributed to ambient temperature, cold being a risk factor for arterial occlusion. (Lloyd, 1991; Wilmshurst, 1994; Khaw, 1995; The Eurowinter Group, 1997) , but could also relate to the well-recognized seasonal fluctuations in vitamin D status found in the UK (McLaughlin et al. 1974; Maxwell, 1994) . Fasting triacylglycerol and blood glucose concentrations, known to be lower in summer than winter in man, move in the opposite direction to seasonal changes in insulin secretion (Fahlen et al. 1971) , showing improvement with the seasonal increases in vitamin D status seen in many European communities (van der Wielen et al. 1995) . The finding that IHD becomes less prevalent at increasing altitude, as temperatures drop but exposure to U.V. radiation is increased, supports the suggestion that vitamin D status may be more important than ambient temperature in determining long-term circulatory risk in these populations (Scragg, 1996) . Neither blood pressure nor serum cholesterol, however, were altered in a recent trial using a single dose of oral vitamin D given in the winter to elderly people re-studied at about 5 weeks later in January and February, although the data for deficient subjects was not examined separately and the authors note that longer periods may be required for any benefits to develop (Scragg et al. 199%) .
It was on this background that we included measurement of vitamin D status in a study of a population of UK Asians which examined glucose tolerance in relation to dietary and anthropomorphic factors in 1990-1 (Boucher, 1995) . Vitamin D deficiency was expected to be rare as a result of increasing medical awareness locally of the need for vigilance in the detection of vitamin D deficiency, and for Asians, in particular, to be advised on the maintenance of adequate vitamin D status. What was found, however, was a 95% prevalence of vitamin D insufficiency (serum 25(OH)D < 20nmol/l) in forty-four subjects deemed to be 'at risk' of glucose intolerance on spot glucose testing, as compared with 80% in a small but comparable group of controls from within the same population. We found vitamin D status (as measured by circulating 25(OH)D) in Bangladeshi Asians to relate largely to diet in the winter months, specifically to the consumption of fish, ghee and, to a lesser degree, the consumption of eggs. Sunshine exposure has a major role in men, since vitamin D status varies with season of the year in our group as in Caucasians in the UK. The seasonal effect was much less, however, in women who are therefore especially dependent on diet throughout the year in this ethnic group. Previous findings showing glucose tolerance and insulin secretory capacity to relate directly to vitamin D status in man were confirmed in this group as follows. We found plasma true insulin, reflecting insulin secretory capacity at 30 min on oral glucose tolerance testing, to improve with increasing vitamin D status, ( I 0.73, P = 0.0001) whilst glucose tolerance was reduced with reduction in vitamin D status ( r -0.3 I , P = 0.04), independent of other risk factors such as age, sex or anthropomorphic features relating to body build, in the group as a whole.
Subjects not known to have diabetes were subdivided into those 'at-risk' of diabetes (spot blood glucose values > 6.4 mmol/l if taken < 2 h after food or > 4.4 mmol/l if taken > 2 h after food) or 'not-at-risk' of diabetes (with spot blood glucose values less than those defining the 'atrisk' group). The same relationships of vitamin D status to insulin secretion and glucose tolerance were found in both subgroups as in the whole group, and were independent of age, weight, sex or body build. (We have found similar relationships in fifty-five vitamin D-deficient subjects but not in 120 non-deficient subjects in a current ongoing study (N Mannan, BJ Boucher, P Mills, K Noonan, D Syndercomb Court and CN Hales, unpublished results).) We also showed that giving a single parenteral dose of 2500 pg vitamin D increased plasma insulin 30 min after a standard 75 g oral glucose load 12 weeks later by a mean of + 160 % in our deficient subjects. Since the improvement in insulin secretory responses to glucose was greatest in those whose insulin responses to oral glucose were nearest to normal to start with, and since we saw no improvement in glycaemia despite these changes, we have a study in progress to determine whether subjects with vitamin D deficiency, 'at risk' of, but without diabetes at oral glucose tolerance testing, can be protected from progression towards NIDDM or from other features of syndrome 'X' by supplementation with vitamin D at 1250pg three monthly over 1 year.
We have also been able to study a group of 142 elderly Dutchmen from the Zutphen subgroup of subjects within the Seven Nation Study, in collaboration with E Feskens and D Kromhout (Baynes et al. 1997) . Of these subjects 39% were vitamin D deficient. We found that vitamin D status related to physical (outdoor) activity rather than to diet. Glucose tolerance in these subjects was inversely related to vitamin D status independent of weight, age, physical activity, diet or of season itself ( r -0.26, P < 0.01). This relationship was independent of fish intake and of the intake of specific fats and oils in this subgroup, despite the finding of an overall long-term protective effect of increasing fish consumption against NIDDM in Seven Nation Study subjects (Feskens et al. 1991) . 
Vitamin D in pregnancy
The possibility that maternal vitamin D deficiency could contribute to the syndrome 'X'-related health risks recently identified as being associated with low birth weight should also be considered. Whilst fetal survival in the presence of maternal malnutrition could be genetically determined, it has been shown experimentally that malnutrition, whether general or of protein, at certain specific stages of pregnancy leads to lack of fetal growth from which catch-up growth is not possible. Such effects are most marked if feeding is reduced during phases of rapid cell division, and it has been suggested that man is 'uniquely likely' to be susceptible to intra-uterine insults in terms of loss of subsequent growth of organs and of final adult height, since human progeny are born at such a relatively advanced stage of development (Widdowson & McCance, 1975) . Since VDR are present in the islet fi cell (Roth et al. 1982; Johnson et al. 1994) , we should also consider whether vitamin D could play a part in programming factors other than birth weight. Vitamin D requirements are increased 4-5-fold in pregnancy, and experimental dietary depletion has been shown to be specifically associated with reduced fetal growth in animals. Vitamin D deficiency is also well known to reduce size and weight in the newborn human infant (Maxwell et al. 1981; Brommage & De Luca, 1984; Marya et al. 1987; Kuoppala, 1988; Nap & Hazewinkel, 1994) . Whilst inadequate protein intake is a prime suspect, this finding suggests that deficiency of vitamin D could be an additional factor in the aetiology of the 'small baby' syndrome defining the 'Thrifty Phenotype' hypothesis. Supplementation is recommended for some groups of pregnant North American women at risk of vitamin D deficiency (Specker, 1994) , and it would be of interest to know whether birth weight, subsequent insulin sensitivity or the glucose tolerance of their offspring may thus be altered.
Recent work has confirmed a reduction in weight and size of mice born to mice with dietary deficiency of vitamin D, with an increase in fasting glycaemia but no change in glucose tolerance in 3-month-old female offspring. Followup glucose tolerance testing, hopefully with blood pressure monitoring, of these offspring as they age will be of particular interest (Desai et al. 1997b) .
Vitamin D in treatment of syndrome 'X'
The possibility that the prevalence of syndrome 'X', and its devastating sequelae, could be reduced by dietary supplementation in pregnancy requires investigation. If demonstrated, this would be a valuable addition to current policies, since compliance with nutritional advice is often good whilst mothers are concerned for the well-being of the unborn child. It is, in contrast, notoriously difficult to achieve compliance with policies advocating long-term lifestyle changes, such as reduction in dietary fat intake, loss of weight and increased physical activity in adults (Tremoli et al. 1986; Henry, 1994) . Prolonged treatment of osteomalacia with vitamin D has been reported to improve glucose tolerance, although short-term treatment has generally been ineffective, despite some increase in insulin secretion, as in our own recent study (Clark et (Lind et al. 1988; Mak, 1992a Mak, , 1994 Kautsky-Willer et al. 1995) . If 1-x-hydroxycholecalciferol is given intravenously for at least 3 months, it reduces triacylglycerol and increases HDL-cholesterol concentrations in the plasma. Correction of hypocalcaemia in a small group of patients with either rickets or hypoparathyroidism improved both insulin secretion and glycaemia (Bansal et al. 1975) . Prophylactic 1,25(OH)2D, or equivalent analogues, are in routine use to prevent renal osteodystrophy. This treatment has the additional beneficial effects of preserving insulin sensitivity and preventing glucose intolerance; indeed, it can also correct these abnormalities if started early (Kautsky-Willer et al. 1995) .
Variation in requirements for vitamin D
Several factors could contribute to differences in vitamin D requirement between individuals, between populations, and with age. These include variations in absorption, in activation, and in rates of removal of 1,25(OH)*D. We have shown, in studies into the marked increase in prevalence of vitamin D deficiency amongst the elderly, that absorption of vitamin D from the gut, for example, is reduced with age (Corless et al. 1975; Barragry et al. 1978) . Reduced Ca absorption from the gut in response to 1,25(OH)*D has also been reported in the elderly as well as reduction in renal 25(OH)D 1 -x-hydroxylase activity, with loss of nephrons with age (as judged by 1,25(OH)*D production in response to parathyroid hormone; Riggs et al. et al. 1992) . The combination of these changes increases susceptibility of the elderly to the development of clinical bone disease, especially when the adequacy of dietary vitamin D is borderline and exposure to U.V. from sunshine is minimal (van der Wielen et al. 1995; Scragg, 1996) . These phenomena must similarly increase the risk of glucose intolerance with age.
1981; Ebeling
Analysis of the data from the Survey in Europe on Nutrition in the Elderly: A Concerted Action, of about 2000 people from nineteen towns and villages in twelve countries across Europe, has shown an increased prevalence of vitamin D deficiency in the elderly from West to East and also from North to South of the Alps (van der Wielen et al. 1995) . Glucose intolerance increased with increasing deficiency in about 900 of these subjects in whom 25(OH)D was measured, whilst insulin resistance, as judged by fasting insulin concentration, increased with increasing vitamin D deficiency, independent of the effects of anthropomorphic markers of diabetic risk (r -0-3 1, P = 0.05 and r -0.21, P = 0.02 respectively; A Teuscher and AU Teuscher, European Association for the Study of Diabetes subgroup on Dietetics and Nutrition 1996, personal communication). Vitamin C has been shown to be necessary for hydroxylation of cholecalciferol to its active form (Cantatore et al. 1991) and, therefore, deficiency may enhance the effects of vitamin D insufficiency.
Vitamin D receptor, post-receptor mechanisms
Earlier work on Asian boys with and without rickets despite comparable diet, vitamin D intake and exposure to sunshine led 0' Hara-May & Widdowson (1976) to postulate that individuals might differ in vitamin D 'requirements' in respect of bone disease. Since the VDR is expressed in islet p cells, and alleles of the VDR gene are believed to relate to severity of osteoporosis in some populations (Morrison et al. 1994; Ferrari et al. 1995) , there is also a possibility that genetic variation in islet p cell VDR activity could be associated with differences in insulin secretory responsiveness. Preliminary examination of our initial findings for insulin secretion during oral glucose tolerance tests, with VDR genotype, has shown significant variation with the AA allele, but not with the BB allele in Bangladeshis (findings with the TT allele are borderline), despite comparability of vitamin D status between subgroups (Hitman et al. 1998) . Vitamin D action is effected after dimerization of its ligand-bound receptors (VDR), often with retinoid X receptors, and modulated by 9-cis retinoic acid (Colston, 1993) inducing transcription of target genes. The interaction of vitamin A and related compounds with post-receptor mechanisms provides an explanation for previously-reported interactions of vitamins A and D. Large oral doses of vitamin A have been shown experimentally to inhibit the expected toxicity of large doses of vitamin D and to induce rachitic changes in animals fed on normal diets (Metz et al. 1985) . Vitamin A induces acute glucose intolerance in man (Chertow et al. 1982) , and we have found it to induce hyperglycaemia in CD1 mice (Motahar & Boucher, 1997) . Inhibition of islet insulin release is found in vitro (Chertow & Baker, 1978) . These findings suggest that consumption of unduly large amounts of vitamin A or related compounds could enhance the diabetogenic risks of vitamin D deficiency. This topic is likely, therefore, to warrant full review from an appropriate expert in the future, especially now that the retinoid X ( a and / 3) receptors have now been found in insulin-secreting cells from the rat (Chertow et al. 1993 (Chertow et al. , 1997 .
Serum vitamin D-binding proteins
Vitamin D stores are estimated by measurement of 25(OH)D bound to vitamin D-binding protein. It is not known whether there is any variation in availability of reserves of vitamin D in relation to the known genotypes of the vitamin D-binding (group-specific component) protein, although their distribution varies with latitude and with skin pigmentation. An increase in prevalence of type 2 diabetes (NIDDM) has been found with the FI-F1 phenotype, which is associated with reduction in insulin secretion. Other combinations of alleles are found in relation to diabetes in the Bantu (Constans et al. 1985; Kamboh & Ferrell, 1986; Szathmary, 1987; Iyengar et al. 1989; Chen et al. 1990; Braun et al. 1992 ) and this aspect of vitamin D availability warrants further consideration.
Immune defence mechanisms
Vitamin D is known to have a role in promoting immune defence mechanisms and to be protective against infections such as tuberculosis (Hewison, 1992; Maxwell, 1994; Strachan et al. 1995) . It can also be protective against some autoimmune processes. The insulitis leading to spontaneous insulin-dependent diabetes in the non-obese diabetic mouse can, for example, be prevented by the administration of the active hormone 1,25(OH)2D and, indeed, by its nonhyperglycaemic analogues (Mathieu et al. 1993 , which may provide interesting therapeutic options for consideration. Subjects with NIDDM in populations with a high risk of progression to insulin requirement may therefore be put at increased risk if they are also vitamin D deficient. The finding of a particularly high incidence of progression to insulin requirement in patients with NIDDM in association with certain human leucocyte antigen markers for insulindependent diabetes is especially intriguing, particularly since islet cell antibodies are a feature in such patients (Groop, 1988) . Our group has recently found certain VDR alleles to be significantly associated with insulin-dependent diabetes, in association with both islet cell antibodies and anti-glutamic acid decarboxylase (EC 4.1.1.15) antibodies in family studies in southern Indians (McDermott et al. 1997) .
Sunshine v. exercise or both? Maxwell (1994) has already suggested to The Nutrition Society that many diseases with increased prevalence in northern latitudes (e.g. seasonal affective disorder, osteoporotic fractures and IHD) could relate to lack of vitamin D due to reduced exposure to sunshine. If disorders clustering with IHD and IGT were similarly linked, one could extend these hypotheses to include not only NIDDM but syndrome 'X'. The (Scragg et al. 1992 . Any benefits of treatment with vitamin D are perhaps more likely to be found in deficient subjects, although significant reduction in blood pressure is found in treating nondeficient people (Lind et al. 1988) .
Fish oil
There is a large amount of literature suggesting a protective effect of dietary fish and of supplemental fish oils against IHD through the n-3 fatty acids (Kromhout et al. Feskens et al. 1993; McKeigue, 1994) . The prevalence of diabetes and IHD has been shown to be reduced with increasing fish consumption in Scandinavians, and with consumption of salmon or of seal oil in Alaska. Unfortunately, vitamin D status was not reported in these studies. The amounts of vitamin D found in fish can vary greatly, Pacific salmon (Salrno onchrhynchus) being said to be a good source of vitamin D whilst Atlantic salmon (Salrno salar), for example, is not. Therapeutic fish-oil preparations can contain 0-0.25 pg vitamin D/g so that it is to be hoped that future studies will include consideration of both vitamin D status and of the content of such foods or treatment (Fraser, 1995; Pritchard et al. 1995) .
Who may be at risk?
Whilst vitamin D is produced in the skin following exposure to U.V. light, there are large areas of the Northern hemisphere where outdoor exposure to sunlight is insufficient for the normal self-regulatory production of active vitamin D to maintain adequate levels throughout the year. Progressive reduction in available sunlight has been shown to be mirrored by increases in population semm cholesterol concentrations in a global meta-analysis (Grimes et al. 1996) . Industrialization and resultant urbanization reduce exposure to sunlight throughout the Western world, and increase dependence on dietary sources of vitamin D. It is not surprising, therefore, that rickets was the first disease recognized as being caused by industrial smoke pollution (Hutchinson & Shah, 1921) . Inadequate exposure to sunlight is common in people with black skins living in northern countries, but is also seen in many places with sunny climates. Rickets was, for example, common in affluent urban communities in Bombay in studies contributing to the discovery that sunlight prevents rickets. Affluent communities were found to live an indoor lifestyle, with children routinely kept indoors from birth to the age of 18 months (Park, 1923; Ihde, 1975) . Vitamin D deficiency is currently widespread in the elderly in California, in Saudi men, the Bedouin and in the elderly across Europe from Britain to Italy, as well as in New Zealand and parts of Finland (Sedrani, 1984; Parviainen et al. 1992; McGrath et al. 1993; Brown & Brenton, 1994; van der Wielen et al. 1995) . If vitamin D deficiency contributes significantly to the risks of syndrome 'X' and glucose intolerance, then clearly large numbers of people are currently at risk, and correction of such deficiency would be desirable.
British diets provide barely enough vitamin D to meet the minimal requirements for those not adequately exposed to U.V. light (10 pg daily; Department of Health and Social Security, 1979) , let alone the increased requirements of pregnancy. The introduction of vitamin D supplementation of milk and some breakfast cereals in various countries should be reducing the prevalence of urban type 2 diabetes, if not of syndrome 'X'. Since Western communities are, however, being advised both officially and in the lay press to avoid eating fat and to beware of the carcinogenic risks of sunlight, specific efforts may have to be made to maintain adequate vitamin D status. The last time that this was done in the UK was during and after the Second World War, when the prevalence of type 2 diabetes fell strikingly. This fall was attributed to diet, especially to the high-fibre Ca-enriched National Loaf (Trowell, 1974) . Wartime Britons were also supplied with cod-liver oil, one of 'five welfare foods for children ' (Ministry of Food, 1945) which could have contributed to this phenomenon. Icelanders currently take cod-liver oil regularly and have less childhood insulin-dependent diabetes than is seen in other European countries; it would be interesting to know whether their prevalence of type 2 diabetes or of IHD is rising or falling (Iyer, 1991; Helgasen et al. 1992) .
Standard vitamin D supplementation for babies fell out of favour after outbreaks of infantile hypercalcaemia due to over-zealous use of supplemented baby foods (Misselwitz et al. 1990) , as it did for adults when excessive intake of fish oils was found to carry atherogenic risks and to increase circulating cholesterol (Davies, 1989; Moon et al. 1992) . Supplementation in the UK is now limited to margarine, some yoghurt, breakfast cereals and, uncommonly, milk, although increased intake of fish is widely recommended as beneficial for the heart by doctors, nutritionists and the media.
If avoidance of vitamin D deficiency were to be the subject of future health promotions, a risk-benefit analysis of dietary supplementation, medication or U.V. light would be required in order to develop a safe and practicable policy for use in health promotion. Modest exposure to sunlight might well prove to be the safest for those with black skin, and is also especially effective in the elderly (Haddad, 1992) , and carries no risk of vitamin D intoxication (see (The Nutrition Society, 1997) . The following conclusions have been drawn, therefore, from the data presented to bring the 'poor relation', vitamin D, to the attention of workers in the field as a risk factor for diabetes, and for syndrome 'X', which is worthy of more general attention.
Conclusions and recommendations
1. The evidence available suggests that assessment of vitamin D status should be considered in the planning of future studies on environmental factors in the aetiology of NIDDM.
2. Assessment of vitamin D status should be included in studies of measures for the prevention of diabetes, unless deficiency is unknown in study subjects.
3. The proposition that vitamin D deficiency may contribute to the abnormalities leading to degenerative disease of the vasculature directly, rather than simply by increasing the risk of diabetes, warrants further investigation.
4. It would be helpful if vitamin D status were assessed, by measurement of circulating 25(OH)D concentration, in any future studies which concern measures of physical activity or diet in relation to insulin sensitivity, secretion, glycaemia or other aspects of syndrome 'X', since many of the features characterizing syndrome 'X' are recognized as being associated with reduced physical (outdoor) activity which itself improves vitamin D status, an effect which could confound studies on the benefits of exercise.
5. 'Normal ranges' for circulating 25(OH)D concentration have been used to define vitamin D status in healthy people adequately exposed to sunlight. Minimal recommended daily intakes of dietary vitamin D are defined by the capacity to prevent rickets and osteomalacia and are expected to maintain serum 2S(OH)D concentration within the normal range. It is possible that there is an optimum for vitamin D status. Adverse effects may result from higher as opposed to lower 'normal' concentrations of serum 25(OH)D, in terms of hyperlipidaemia or other metabolic changes; optimal vitamin D status, therefore, may need to be re-defined. It would be especially desirable to examine this hypothesis in pre-morbid populations with a high risk of degenerative heart disease. 6. The effects of treating deficient subjects with vitamin D should be clearly distinguished from the effects of supplementation in non-deficient subjects, both in the examination of findings relevant to glycaemia, and of findings relevant to lipidaemia, thrombogenesis or other markers of syndrome 'X', since such effects may vary with status.
7. Whilst the avoidance of vitamin D deficiency remains a desirable measure for the promotion of good health, attempts to maintain serum concentrations of 2S(OH)D at or above the upper limit of current normal ranges should be avoided until the questions posed by the current state of knowledge have been answered. 9. The possibility that the adverse effects of large intakes of dietary fish oils on glycaemia may relate to their very considerable vitamin A content requires investigation, since supplementation with vitamin D, free of vitamin A, is also widely available.
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